Point-of-Care Molecular Diagnostics�-Global Market Status and Trend Report 2013-2023 | Mart Research
市场研究趋势,行业分析报告沃尔玛研究

Point-of-Care Molecular Diagnostics�-Global Market Status and Trend Report 2013-2023

  • 概要
  • 目录
  • 表和图
Report Summary Point-of-Care Molecular Diagnostics�-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Point-of-Care Molecular Diagnostics� industry, standing on the readers� perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include: Worldwide and Regional Market Size of Point-of-Care Molecular Diagnostics� 2013-2017, and development forecast 2018-2023 Main manufacturers/suppliers of Point-of-Care Molecular Diagnostics� worldwide, with company and product introduction, position in the Point-of-Care Molecular Diagnostics� market Market status and development trend of Point-of-Care Molecular Diagnostics� by types and applications Cost and profit status of Point-of-Care Molecular Diagnostics�, and marketing status Market growth drivers and challenges The report segments the global Point-of-Care Molecular Diagnostics� market as: Global Point-of-Care Molecular Diagnostics� Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023): North America Europe China Japan Rest APAC Latin America Global Point-of-Care Molecular Diagnostics� Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023): PCR-based Genetic Sequencing-based Hybridization-based Microarray-based Global Point-of-Care Molecular Diagnostics� Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis) Infectious Diseases Oncology Hematology Prenatal Testing Endocrinology Other Global Point-of-Care Molecular Diagnostics� Market: Manufacturers Segment Analysis (Company and Product introduction, Point-of-Care Molecular Diagnostics� Sales Volume, Revenue, Price and Gross Margin): Danaher Corporation Johnson and Johnson BioMerieux F. Hoffmann-La Roche AG Abbott Laboratories, Bayer Healthcare Becton, Dickinson and Company Cepheid, Inc. Bio-Rad Laboratories, Inc. In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
目录Chapter 1 Overview of Point-of-Care Molecular Diagnostics� 1.1 Definition of Point-of-Care Molecular Diagnostics� in This Report 1.2 Commercial Types of Point-of-Care Molecular Diagnostics� 1.2.1 PCR-based 1.2.2 Genetic Sequencing-based 1.2.3 Hybridization-based 1.2.4 Microarray-based 1.3 Downstream Application of Point-of-Care Molecular Diagnostics� 1.3.1 Infectious Diseases 1.3.2 Oncology 1.3.3 Hematology 1.3.4 Prenatal Testing 1.3.5 Endocrinology 1.3.6 Other 1.4 Development History of Point-of-Care Molecular Diagnostics� 1.5 Market Status and Trend of Point-of-Care Molecular Diagnostics� 2013-2023 1.5.1 Global Point-of-Care Molecular Diagnostics� Market Status and Trend 2013-2023 1.5.2 Regional Point-of-Care Molecular Diagnostics� Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Point-of-Care Molecular Diagnostics� 2013-2017 2.2 Production Market of Point-of-Care Molecular Diagnostics� by Regions 2.2.1 Production Volume of Point-of-Care Molecular Diagnostics� by Regions 2.2.2 Production Value of Point-of-Care Molecular Diagnostics� by Regions 2.3 Demand Market of Point-of-Care Molecular Diagnostics� by Regions 2.4 Production and Demand Status of Point-of-Care Molecular Diagnostics� by Regions 2.4.1 Production and Demand Status of Point-of-Care Molecular Diagnostics� by Regions 2013-2017 2.4.2 Import and Export Status of Point-of-Care Molecular Diagnostics� by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Point-of-Care Molecular Diagnostics� by Types 3.2 Production Value of Point-of-Care Molecular Diagnostics� by Types 3.3 Market Forecast of Point-of-Care Molecular Diagnostics� by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Point-of-Care Molecular Diagnostics� by Downstream Industry 4.2 Market Forecast of Point-of-Care Molecular Diagnostics� by Downstream Industry Chapter 5 Market Driving Factor Analysis of Point-of-Care Molecular Diagnostics� 5.1 Global Economy Situation and Trend Overview 5.2 Point-of-Care Molecular Diagnostics� Downstream Industry Situation and Trend Overview Chapter 6 Point-of-Care Molecular Diagnostics� Market Competition Status by Major Manufacturers 6.1 Production Volume of Point-of-Care Molecular Diagnostics� by Major Manufacturers 6.2 Production Value of Point-of-Care Molecular Diagnostics� by Major Manufacturers 6.3 Basic Information of Point-of-Care Molecular Diagnostics� by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Point-of-Care Molecular Diagnostics� Major Manufacturer 6.3.2 Employees and Revenue Level of Point-of-Care Molecular Diagnostics� Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Point-of-Care Molecular Diagnostics� Major Manufacturers Introduction and Market Data 7.1 Danaher Corporation 7.1.1 Company profile 7.1.2 Representative Point-of-Care Molecular Diagnostics� Product 7.1.3 Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Danaher Corporation 7.2 Johnson and Johnson 7.2.1 Company profile 7.2.2 Representative Point-of-Care Molecular Diagnostics� Product 7.2.3 Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Johnson and Johnson 7.3 BioMerieux 7.3.1 Company profile 7.3.2 Representative Point-of-Care Molecular Diagnostics� Product 7.3.3 Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of BioMerieux 7.4 F. Hoffmann-La Roche AG 7.4.1 Company profile 7.4.2 Representative Point-of-Care Molecular Diagnostics� Product 7.4.3 Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche AG 7.5 Abbott Laboratories, Bayer Healthcare 7.5.1 Company profile 7.5.2 Representative Point-of-Care Molecular Diagnostics� Product 7.5.3 Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Abbott Laboratories, Bayer Healthcare 7.6 Becton, Dickinson and Company 7.6.1 Company profile 7.6.2 Representative Point-of-Care Molecular Diagnostics� Product 7.6.3 Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company 7.7 Cepheid, Inc. 7.7.1 Company profile 7.7.2 Representative Point-of-Care Molecular Diagnostics� Product 7.7.3 Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Cepheid, Inc. 7.8 Bio-Rad Laboratories, Inc. 7.8.1 Company profile 7.8.2 Representative Point-of-Care Molecular Diagnostics� Product 7.8.3 Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories, Inc. Chapter 8 Upstream and Downstream Market Analysis of Point-of-Care Molecular Diagnostics� 8.1 Industry Chain of Point-of-Care Molecular Diagnostics� 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Point-of-Care Molecular Diagnostics� 9.1 Cost Structure Analysis of Point-of-Care Molecular Diagnostics� 9.2 Raw Materials Cost Analysis of Point-of-Care Molecular Diagnostics� 9.3 Labor Cost Analysis of Point-of-Care Molecular Diagnostics� 9.4 Manufacturing Expenses Analysis of Point-of-Care Molecular Diagnostics� Chapter 10 Marketing Status Analysis of Point-of-Care Molecular Diagnostics� 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference
List of Tables Table Advantage and Disadvantage of PCR-based Table Advantage and Disadvantage of Genetic Sequencing-based Table Advantage and Disadvantage of Hybridization-based Table Advantage and Disadvantage of Microarray-based Table Production Volume of Point-of-Care Molecular Diagnostics� by Regions 2013-2017 Table Production Value of Point-of-Care Molecular Diagnostics� by Regions 2013-2017 Table Demand Volume of Point-of-Care Molecular Diagnostics� by Regions 2013-2017 Table Production and Demand Status of Point-of-Care Molecular Diagnostics� in Region One 2013-2017 Table Production and Demand Status of Point-of-Care Molecular Diagnostics� in Region Two 2013-2017 Table Production and Demand Status of Point-of-Care Molecular Diagnostics� in Region Three 2013-2017 Table Production and Demand Status of Point-of-Care Molecular Diagnostics� in Region Four 2013-2017 Table Import Volume of Point-of-Care Molecular Diagnostics� by Regions 2013-2017 Table Export Volume of Point-of-Care Molecular Diagnostics� by Regions 2013-2017 Table Production Volume of Point-of-Care Molecular Diagnostics� by Types 2013-2017 Table Production Value of Point-of-Care Molecular Diagnostics� by Types 2013-2017 Table Production Volume Forecast of Point-of-Care Molecular Diagnostics� by Types 2018-2023 Table Production Value Forecast of Point-of-Care Molecular Diagnostics� by Types 2018-2023 Table Demand Volume of Point-of-Care Molecular Diagnostics� by Downstream Industry 2013-2017 Table Demand Volume Forecast of Point-of-Care Molecular Diagnostics� by Downstream Industry 2018-2023 Table Production Volume of Point-of-Care Molecular Diagnostics� by Major Manufacturers 2013-2017 Table Production Value of Point-of-Care Molecular Diagnostics� by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Point-of-Care Molecular Diagnostics� Major Manufacturer Table Employees and Revenue Level of Point-of-Care Molecular Diagnostics� Major Manufacturer Table Representative Point-of-Care Molecular Diagnostics� Product One of Danaher Corporation Table Representative Point-of-Care Molecular Diagnostics� Product Two of Danaher Corporation Table Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Danaher Corporation 2013-2017 Table Representative Point-of-Care Molecular Diagnostics� Product One of Johnson and Johnson Table Representative Point-of-Care Molecular Diagnostics� Product Two of Johnson and Johnson Table Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Johnson and Johnson 2013-2017 Table Representative Point-of-Care Molecular Diagnostics� Product One of BioMerieux Table Representative Point-of-Care Molecular Diagnostics� Product Two of BioMerieux Table Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of BioMerieux 2013-2017 Table Representative Point-of-Care Molecular Diagnostics� Product One of F. Hoffmann-La Roche AG Table Representative Point-of-Care Molecular Diagnostics� Product Two of F. Hoffmann-La Roche AG Table Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche AG 2013-2017 Table Representative Point-of-Care Molecular Diagnostics� Product One of Abbott Laboratories, Bayer Healthcare Table Representative Point-of-Care Molecular Diagnostics� Product Two of Abbott Laboratories, Bayer Healthcare Table Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Abbott Laboratories, Bayer Healthcare 2013-2017 Table Representative Point-of-Care Molecular Diagnostics� Product One of Becton, Dickinson and Company Table Representative Point-of-Care Molecular Diagnostics� Product Two of Becton, Dickinson and Company Table Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company 2013-2017 Table Representative Point-of-Care Molecular Diagnostics� Product One of Cepheid, Inc. Table Representative Point-of-Care Molecular Diagnostics� Product Two of Cepheid, Inc. Table Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Cepheid, Inc. 2013-2017 Table Representative Point-of-Care Molecular Diagnostics� Product One of Bio-Rad Laboratories, Inc. Table Representative Point-of-Care Molecular Diagnostics� Product Two of Bio-Rad Laboratories, Inc. Table Point-of-Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories, Inc. 2013-2017
付款方式

请留言 向上箭头